Literature DB >> 15789179

Self-management of oral anticoagulant therapy: a review.

Thomas D Christensen1.   

Abstract

Patient self-management of oral anticoagulant therapy has over the last years gained increasing attention and widespread use. The method implies self-testing using a coagulometer (point-of-care device) and self-dosaging of coumarin. The method entails advantages for selected patients, who do not need to go to the hospital or family doctor for blood specimen and drug dosage adjustment. In contrast to patients on conventional management, patients performing self-managing have a reduced binding to the health care system, and it allows these patients unhindered to travel and manage their job or school. Therefore, the patients have a high degree of compliance because they are highly motivated. This has been the main justification for patient self-management. Furthermore, the conducted trials have also indicated a better quality of treatment compared to conventional management. In this paper the different aspects of this new treatment modality are critically reviewed, with special focus on the published clinical studies and the evaluation of the used coagulometers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15789179     DOI: 10.1007/s11239-004-0209-5

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  7 in total

Review 1.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Topical issues in venous thromboembolism.

Authors:  José Ignacio Abad Rico; Juan Vicente Llau Pitarch; José Antonio Páramo Fernández
Journal:  Drugs       Date:  2010-12-14       Impact factor: 9.546

3.  Quality of oral anticoagulant therapy in patients who perform self management: warfarin versus phenprocoumon.

Authors:  Christina Friis Jensen; Thomas Decker Christensen; Marianne Maegaard; John Michael Hasenkam
Journal:  J Thromb Thrombolysis       Date:  2008-09-25       Impact factor: 2.300

4.  Ten-year experience with acenocoumarol treatment in an ambulatory cohort of Spanish patients.

Authors:  Joan-Carles Trullas-Vila; Josep Bisbe-Company; Adriana Freitas-Ramírez; Silvia Soler-Simon; Vicenta Bisbe-Company; Josep-Maria Roncero-Vidal; Rosa Gispert-Magarolas
Journal:  J Thromb Thrombolysis       Date:  2009-02-19       Impact factor: 2.300

5.  Effects of computer-assisted oral anticoagulant therapy.

Authors:  Rune Skovgaard Rasmussen; Pernille Corell; Poul Madsen; Karsten Overgaard
Journal:  Thromb J       Date:  2012-08-30

6.  Security and cost comparison of INR self-testing and conventional hospital INR testing in patients with mechanical heart valve replacement.

Authors:  Qiu-lin Chen; Li Dong; Yi-jun Dong; Shu-lin Zhao; Bo Fu; Yu-qing Wang; Hong Jiang
Journal:  J Cardiothorac Surg       Date:  2015-01-16       Impact factor: 1.637

7.  Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings.

Authors:  Bárbara Menéndez-Jándula; José Antonio García-Erce; Clara Zazo; Luis Larrad-Mur
Journal:  BMC Cardiovasc Disord       Date:  2019-08-02       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.